IXJ Performance — iShares Global Healthcare ETF
Data updated: 2026-08-24
IXJ returned +1.96% year to date and +15.92% over one year to Jun 2026. Annualised returns are +6.55% over 3 years and +4.87% over 5 years. The fund trailed its Global Health Care Equity category average: $100 invested three years ago grew to $121, against $130 for the category, and to $116 over one year, against $124. Volatility over the past three years was 13.33% a year. In the 12 months to Jun 2026 the fund lost a net $455.1M, and assets reached $3.84B.
IXJ Growth of $100
What $100 invested in iShares Global Healthcare ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Health Care Equity category average over the same months.
| Period | IXJ | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $116 | $124 |
| 3 years (Jul 2023 – Jun 2026) | $121 | $130 |
| 5 years (Jul 2021 – Jun 2026) | $127 | $104 |
| Since data start (Jul 2019 – Jun 2026) | $176 | $160 |
IXJ Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.96% |
| 1 year | +15.92% |
| 3 years (annualised) | +6.55% |
| 5 years (annualised) | +4.87% |
IXJ Annual Returns
Calendar-year total returns of iShares Global Healthcare ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.96% |
| 2025 | +14.85% |
| 2024 | +0.59% |
| 2023 | +3.48% |
| 2022 | −4.69% |
| 2021 | +19.50% |
| 2020 | +12.48% |
| 2019 (Jul–Dec) | +12.44% |
IXJ Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.5% | +3.1% | −8.1% | −0.8% | +1.7% | +4.9% | — | — | — | — | — | — |
| 2025 | +6.4% | +1.8% | −2.2% | −2.1% | −3.8% | +1.3% | −3.5% | +5.5% | +1.3% | +2.7% | +8.2% | −0.8% |
| 2024 | +2.4% | +2.4% | +2.4% | −4.0% | +3.0% | +1.6% | +3.3% | +5.5% | −3.0% | −5.0% | −0.8% | −6.4% |
| 2023 | −0.7% | −4.5% | +3.5% | +3.5% | −3.8% | +3.1% | +1.2% | −1.0% | −3.2% | −3.7% | +5.5% | +4.3% |
| 2022 | −6.9% | −0.7% | +4.8% | −4.3% | +0.9% | −3.2% | +3.1% | −6.2% | −4.0% | +8.6% | +6.0% | −1.6% |
| 2021 | +0.5% | −2.8% | +3.1% | +3.5% | +2.4% | +2.6% | +3.5% | +2.8% | −5.3% | +4.3% | −3.5% | +7.6% |
| 2020 | −1.5% | −7.0% | −3.4% | +11.2% | +3.5% | −1.4% | +4.0% | +2.3% | −1.8% | −5.0% | +9.0% | +3.4% |
| 2019 | — | — | — | — | — | — | −1.2% | +0.1% | +0.1% | +5.1% | +4.3% | +3.6% |
IXJ Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.33%
- 3-year Sharpe ratio: 0.15 (vs 4.5% risk-free rate)
- Best month: +8.23% (Nov 2025)
- Worst month: −8.05% (Mar 2026)
IXJ Fund Flows
Monthly money in and out of iShares Global Healthcare ETF, from SEC Form N-PORT.
- 12-month net flow: −$455.1M
- 12-month gross sales (incl. reinvestments): $649.0M
- Sales ÷ redemptions: 0.59×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $131.3M | $99.8M | $31.5M |
| May 2026 | $0 | $9.2M | −$9.2M |
| Apr 2026 | $80.0M | $61.1M | $18.9M |
| Mar 2026 | $0 | $243.2M | −$243.2M |
| Feb 2026 | $0 | $558.0M | −$558.0M |
| Jan 2026 | $188.9M | $132.8M | $56.1M |
| Dec 2025 | $53.2M | $0 | $53.2M |
| Nov 2025 | $85.4M | $0 | $85.4M |
| Oct 2025 | $110.1M | $0 | $110.1M |
| Sep 2025 | $0 | $0 | $0 |
| Aug 2025 | $0 | $0 | $0 |
| Jul 2025 | $0 | $0 | $0 |
IXJ Assets Under Management
Net assets of iShares Global Healthcare ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $3.84B |
| 2026-03-31 | $3.62B |
| 2025-12-31 | $4.50B |
| 2025-09-30 | $3.87B |
| 2025-06-30 | $3.75B |
| 2025-03-31 | $3.95B |
| 2024-12-31 | $3.65B |
| 2024-09-30 | $4.29B |
| 2024-06-30 | $4.01B |
| 2024-03-31 | $4.11B |
| 2023-12-31 | $4.04B |
| 2023-09-30 | $3.94B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.